Assessing Sarepta Therapeutics: Insights From 38 Financial Analysts

Latest Ratings for SRPT

Date Firm Action From To
Mar 2022 Morgan Stanley Maintains Equal-Weight
Mar 2022 RBC Capital Maintains Outperform
Feb 2022 Morgan Stanley Maintains Equal-Weight

View More Analyst Ratings for SRPT

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *